AG真人官方

Karpus Management, Inc. filed Amendment No. 2 to Schedule 13G for Eureka Acquisition Corp (EURKU) covering the event date 30 June 2025.

The registered investment adviser now reports beneficial ownership of 327,400 common shares, representing 4.28 % of the outstanding class. Karpus holds sole voting and dispositive power over the entire position and no shared power with other parties. Because the stake has fallen below the 5 % threshold, Karpus is no longer deemed a 5 % beneficial owner under Section 13(d) of the Exchange Act but remains subject to Rule 13d-1(b) reporting requirements.

The shares are held in discretionary advisory accounts managed by Karpus, which operates independently of its parent, City of London Investment Group plc, through established informational barriers. The filing affirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.

Implications for investors: the reduction slightly increases EURKU鈥檚 public float and removes Karpus from the list of significant 5 % holders, potentially diminishing expectations of activist involvement. Nonetheless, a 4.28 % position remains a meaningful minority interest that could provide ongoing institutional oversight.

Karpus Management, Inc. filed Amendment No. 2 to Schedule 13G for Eureka Acquisition Corp (EURKU) covering the event date 30 June 2025.

The registered investment adviser now reports beneficial ownership of 327,400 common shares, representing 4.28 % of the outstanding class. Karpus holds sole voting and dispositive power over the entire position and no shared power with other parties. Because the stake has fallen below the 5 % threshold, Karpus is no longer deemed a 5 % beneficial owner under Section 13(d) of the Exchange Act but remains subject to Rule 13d-1(b) reporting requirements.

The shares are held in discretionary advisory accounts managed by Karpus, which operates independently of its parent, City of London Investment Group plc, through established informational barriers. The filing affirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.

Implications for investors: the reduction slightly increases EURKU鈥檚 public float and removes Karpus from the list of significant 5 % holders, potentially diminishing expectations of activist involvement. Nonetheless, a 4.28 % position remains a meaningful minority interest that could provide ongoing institutional oversight.

Karpus Management, Inc. filed Amendment No. 2 to Schedule 13G for Eureka Acquisition Corp (EURKU) covering the event date 30 June 2025.

The registered investment adviser now reports beneficial ownership of 327,400 common shares, representing 4.28 % of the outstanding class. Karpus holds sole voting and dispositive power over the entire position and no shared power with other parties. Because the stake has fallen below the 5 % threshold, Karpus is no longer deemed a 5 % beneficial owner under Section 13(d) of the Exchange Act but remains subject to Rule 13d-1(b) reporting requirements.

The shares are held in discretionary advisory accounts managed by Karpus, which operates independently of its parent, City of London Investment Group plc, through established informational barriers. The filing affirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.

Implications for investors: the reduction slightly increases EURKU鈥檚 public float and removes Karpus from the list of significant 5 % holders, potentially diminishing expectations of activist involvement. Nonetheless, a 4.28 % position remains a meaningful minority interest that could provide ongoing institutional oversight.

Karpus Management, Inc. filed Amendment No. 2 to Schedule 13G for Eureka Acquisition Corp (EURKU) covering the event date 30 June 2025.

The registered investment adviser now reports beneficial ownership of 327,400 common shares, representing 4.28 % of the outstanding class. Karpus holds sole voting and dispositive power over the entire position and no shared power with other parties. Because the stake has fallen below the 5 % threshold, Karpus is no longer deemed a 5 % beneficial owner under Section 13(d) of the Exchange Act but remains subject to Rule 13d-1(b) reporting requirements.

The shares are held in discretionary advisory accounts managed by Karpus, which operates independently of its parent, City of London Investment Group plc, through established informational barriers. The filing affirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.

Implications for investors: the reduction slightly increases EURKU鈥檚 public float and removes Karpus from the list of significant 5 % holders, potentially diminishing expectations of activist involvement. Nonetheless, a 4.28 % position remains a meaningful minority interest that could provide ongoing institutional oversight.

Form 144 filed for Arqit Quantum Inc. Warrants (ARQQW) discloses a proposed sale of 238 common shares through Fidelity Brokerage Services on 02 July 2025. The aggregate market value of the planned sale is $8,151.83, compared with 11,545,354 shares outstanding, representing less than 0.01 % of total shares. The filing also lists prior insider dispositions by Daniel Shiu during the past three months totalling 6,730 shares for $250,358.61 in gross proceeds. Shares to be sold were acquired via restricted-stock vesting on 01 July 2025 as compensation. The signer affirms no undisclosed material adverse information. No additional financial metrics or operational updates are provided.

Form 4 overview: Director Guillermo Novo reported the acquisition of 329.5435 phantom stock units of PPG Industries, Inc. (ticker: PPG) on 07 / 01 / 2025. Phantom stock units are deferred-compensation derivatives that convert to common shares on a one-for-one basis after the director leaves the board. Following the transaction, Novo now beneficially owns 9,904.2202 phantom stock units within PPG鈥檚 Deferred Compensation Plan for Directors.

The transaction was coded 鈥淎,鈥� indicating an acquisition rather than a sale, and was effected at a reference price of $116.41 per underlying share. Ownership remains direct (D); no indirect holdings were reported. The filing contains no open-market purchases or sales of PPG common stock and no changes to executive roles or company strategy.

Because phantom units are non-tradable, unfunded, and settled only upon board departure, the event is largely administrative and has negligible impact on public float, cash flow, or near-term earnings. It does, however, signal continued alignment of the director鈥檚 economic interests with long-term shareholder value.

GS Finance Corp., a subsidiary of The Goldman Sachs Group, Inc., has filed a preliminary Rule 424(b)(2) pricing supplement for two separate tranches of Leveraged Buffered Index-Linked Notes under its Medium-Term Notes, Series F program. Each tranche references a single equity index鈥攖he S&P 500庐 Index (CUSIP 40058JKF1) or the Russell 2000庐 Index (CUSIP 40058JKE4)鈥攁nd is fully and unconditionally guaranteed by The Goldman Sachs Group, Inc.

Key economic terms (to be fixed on the July 28 2025 trade date):

• Face amount: $1,000 denominations; initial issue expected July 31 2025.
• Tenor: approximately 2.5 years, maturing on or about February 2 2028.
• No coupons: the notes do not bear periodic interest.
• Upside: 200% participation in positive index performance, capped at a maximum settlement amount of at least $1,212.50 (SPX) and $1,273.50 (RTY) per $1,000 face, translating to maximum gross returns of roughly 21.25% and 27.35%, respectively.
• Downside protection: 10% buffer; investors absorb losses only if the index declines more than 10% from the initial level, after which losses are 1-for-1 beyond the buffer.
• Estimated value: $925-$955 per $1,000 face at pricing, i.e., 4.5-7.5% below issue price, reflecting embedded fees and hedging costs.
• Secondary market: Goldman Sachs & Co. LLC (GS&Co.) may act as market maker but is not obligated; liquidity and pricing will reflect GS&Co.鈥檚 bid-ask spread and declining embedded fees.

Risk highlights disclosed in 鈥淎dditional Risk Factors鈥� include credit risk of both the issuer and guarantor, capped upside, potential for substantial principal loss beyond the 10% buffer, valuation below issue price at inception, limited liquidity, conflicts of interest (GS&Co. is both underwriter and calculation agent) and uncertain tax treatment (pre-paid derivative characterization, FATCA exposure, possible future IRS guidance).

Investors should view the notes as short-dated, leveraged structured products that trade off limited downside protection against a hard cap on gains and significant embedded fees. Suitability hinges on a moderately bullish view of the chosen index within the buffer/cap parameters, tolerance for Goldman credit risk and acceptance of illiquidity and tax complexity.

Form 4 highlights: On 07/01/2025, Mario J. Gabelli reported a sale of 5,000 GCV common shares at an average price of $3.8155 per share, generating proceeds of roughly $19,100. Following the transaction, Mr. Gabelli still directly holds 481,501 shares.

The filing also discloses substantial indirect holdings through related entities: 1,089,000 shares via GGCP, Inc., 17,575 shares via Gabelli & Company Investment Advisers, Inc., and 326,425 shares via Associated Capital Group, Inc. Mr. Gabelli disclaims beneficial ownership in excess of his indirect pecuniary interest.

Given the small size of the sale relative to Mr. Gabelli鈥檚 aggregate position of approximately 1.9 million shares, the transaction appears routine and does not materially change insider ownership levels.

Emily M. Leproust, Chief Executive Officer and Director of Twist Bioscience, reported insider trading activity on June 20, 2025. The transaction involved a mandatory "sell to cover" of 1,678 shares of Common Stock at $35.755 per share to satisfy tax withholding obligations related to vesting Restricted Stock Units.

Following the transaction, Leproust maintains direct ownership of 645,782 shares of Common Stock. Additionally, she holds several employee stock options:

• 150,879 options at $8.82 (expires 09/28/2027)
• 266,539 options at $26.66 (expires 11/18/2028)
• 131,290 options at $23.33 (expires 10/23/2029)
• 64,950 performance-based options at $67.85 (expires 08/31/2030)

The reported sale was not discretionary but rather mandated by the company's equity incentive plan requirements for tax withholding purposes.